Neda Valian

Neda Valian

Auto-generated profile, based on publicly available information

Neda Valian

Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2021 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
PDF file
FIFarideh Iravanpour
Farideh Iravanpour
LDLeila Dargahi
Leila Dargahi
MRMohsen Rezaei
Mohsen Rezaei
MHMasoud Haghani
Masoud Haghani
RHReza Heidari
Reza Heidari
AAAbolhassan Ahmadiani
Abolhassan Ahmadiani
Aims: Experimental and clinical evidences demonstrate that common dysregulated pathways are involved in Parkinson’s disease (PD) and type 2 diabetes. Recently, insulin treatment through intranasal (IN) approach has gained attention in PD, although the underlying mechanism of its potential therapeutic effects is still unclear. In this study, we investigated the effects of insulin treatment in a rat model of PD with emphasis on mitochondrial function indices in striatum.Methods: Rats were treated with a daily low dose (4IU/day) of IN insulin, starting 72 h after 6‐OHDA‐induced lesion and continued for 14 days. Motor performance, dopaminergic cell survival, mitochondrial dehydrogenases activity, mitochondrial swelling, mitochondria permeability transition pore (mPTP), mitochondrial membrane potential (Δψm), reactive oxygen species (ROS) formation, and glutathione (GSH) content in mitochondria, mitochondrial adenosine triphosphate (ATP), and the gene expression of PGC‐1α, TFAM, Drp‐1, GFAP, and Iba‐1 were assessed.Results: Intranasal insulin significantly reduces 6‐OHDA‐induced motor dysfunction and dopaminergic cell death. In parallel, it improves mitochondrial function indices and modulates mitochondria biogenesis and fission as well as activation of astrocytes and microglia.Conclusion: Considering the prominent role of mitochondrial dysfunction in PD pathology, IN insulin as a disease‐modifying therapy for PD should be considered for extensive research.

10 August 2024 in European Journal of Pharmacology
Verified
Journal Article
Closed access
MFMohsen Farhangian
Mohsen Farhangian
FAForouzan Azarafrouz
Forouzan Azarafrouz
NVNeda Valian
Neda Valian
LDLeila Dargahi
Leila Dargahi

3 September 2024 in Behavioural Brain Research
Verified
Journal Article
Closed access
NSNahid Sarahian
Nahid Sarahian
FKFariba Khodagholi
Fariba Khodagholi
NVNeda Valian
Neda Valian
AAAbolhassan Ahmadiani
Abolhassan Ahmadiani

13 March 2022 in Clinical Case Reports
Verified
Journal Article
Open access
MSMehri Salari
Mehri Salari
MEMasoud Etemadifar
Masoud Etemadifar
LDLeila Dargahi
Leila Dargahi
NVNeda Valian
Neda Valian
MRMalihe Rezaee
Malihe Rezaee
Here, we introduced a patient with Mn‐induced parkinsonism who was responsive to intranasal insulin, and his parkinsonism and dystonia responded to this treatment.

11 June 2024 in Iranian Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
FHFatemeh Hemmati
Fatemeh Hemmati
NVNeda Valian
Neda Valian
AAAbolhassan Ahmadiani
Abolhassan Ahmadiani
ZMZahurin Mohamed
Zahurin Mohamed
RARaymond Azman Ali
Raymond Azman Ali
SSSeyed Farshad Hosseini Shirazi
Seyed Farshad Hosseini Shirazi
Background: Insulin resistance is an important pathological hallmark of Parkinson’s disease (PD). Proinflammatory cytokines during neuroinflammation decrease insulin sensitivity by suppressing insulin signaling elements. Toll-like receptor 4 (TLR4), the main receptor involved in neuroinflammation, is also associated with the pathogenesis of PD. Objectives: The present study evaluated the effect of insulin, an insulin receptor antagonist, and a TLR4 inhibitor on behavioral deficits and insulin resistance induced by 6-hydroxydopamine (6-OHDA). Methods: Male Wistar rats were divided into nine groups: (1) sham (normal saline [NS] in the medial forebrain bundle [MFB]); (2) 6-OHDA (20 µg in the MFB); (3) 6-OHDA + NS; (4) 6-OHDA + dimethyl sulfoxide (DMSO); (5) 6-OHDA + insulin (2.5 IU/day, intracerebroventricular ([ICV]); (6) 6-OHDA + insulin (5 IU/day, intranasal [IN]); (7) 6-OHDA + insulin receptor antagonist (S961; 6.5 nM/kg, ICV); (8) 6-OHDA + TLR4 inhibitor (TAK242; 0.01 µg/rat, ICV); (9) 6-OHDA + insulin + TLR4 inhibitor. All treatments were administered for seven consecutive days. Motor performance was evaluated using apomorphine-induced rotation and cylinder tests. Gene expression and protein levels of α-synuclein, TLR4, insulin receptor substrate (IRS) 1, IRS2, and glycogen synthase kinase 3β (GSK3β) were measured by real-time PCR and western blotting, respectively, in the striatum. Results: Insulin, alone and with TAK242, improved motor deficits induced by 6-OHDA. Administration of the insulin receptor antagonist had no effect on motor deficits. The increased expression of α-synuclein and TLR4 following 6-OHDA was attenuated by insulin and TAK242. GSK3β levels, both mRNA and protein, were significantly increased by 6-OHDA and attenuated with insulin and TAK242. Conclusions: The findings suggest that 6-OHDA induces neurodegeneration via activation of TLR4 and GSK3β, indicating insulin resistance, and that insulin can improve these impairments. Moreover, TLR4 inhibition prevents insulin signaling dysfunction and improves behavioral and molecular impairments, highlighting the critical role of TLR4 in the development of insulin resistance in PD pathology.

1 March 2021 in Basic and Clinical Neuroscience Journal
Verified
Journal Article
Open access
PDF file
NVNeda Valian
Neda Valian
MHMansooreh Heravi
Mansooreh Heravi
AAAbolhassan Ahmadiani
Abolhassan Ahmadiani
LDLeila Dargahi
Leila Dargahi
Introduction: Midbrain dopaminergic neurons are involved in various brain functions, including motor behavior, reinforcement, motivation, learning, and cognition. Primary dopaminergic neurons and also several lines of these cells are extensively used in cell culture studies. Primary dopaminergic neurons prepared from rodents have been cultured in both DMEM/F12 and neurobasal mediums ...